Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Nuvau Minerals Strengthens Its Board and Technical Team with the Appointment of David Palmer as a Director and Michael Sutton as Technical Advisor to the Board
Pinnacle Reopens Additional Historic Mine Workings at El Potrero and Samples up to 26.1 g/t Au and 511 g/t Ag